CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)
Revenues	$ 148,190	$ 110,927	$ 285,148	$ 211,533
Transaction costs ($338 and $658 interest expense and fees associated with related party transaction during the three and six months ended June 30, 2022, respectively; refer to Notes 6 and 14 for further information)	26,212	28,521	51,787	48,676
Other operating expenses	35,392	32,010	70,151	58,624
Research and development expenses	26,607	18,541	52,522	35,194
Sales and marketing expenses	36,820	27,702	71,289	50,841
General and administrative expenses	20,192	18,163	38,320	28,680
Depreciation and amortization	5,171	4,351	9,626	9,028
Total operating expenses	150,394	129,288	293,695	231,043
Operating loss	(2,204)	(18,361)	(8,547)	(19,510)
Financial income (expense):
Gain from change in fair value of Warrants	12,831	12,076	44,027	12,076
Other financial expense, net	(4,824)	(2,937)	(7,519)	(3,559)
Financial income (expense), net	8,007	9,139	36,508	8,517
Income (loss) before taxes on income and share of gain (loss) of associated company	5,803	(9,222)	27,961	(10,993)
Taxes on income	1,374	3,197	3,341	4,928
Share in gain (loss) of associated company	(7)	5	13	(1)
Net income (loss)	$ 4,422	$ (12,414)	$ 24,633	$ (15,922)
Per share data
Net income (loss) per share attributable to common stockholders - Basic earnings (loss) per share	$ 0.01	$ (0.63)	$ 0.07	$ (0.84)
Diluted earnings (loss) per share	$ 0.01	$ (0.63)	$ 0.07	$ (0.84)
Weighted average common shares outstanding - Basic and diluted	345,522,076	66,744,348	345,831,177	58,702,320
Weighted average common shares outstanding - Diluted	366,013,696	66,744,348	369,047,627	58,702,320